Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-22PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation
-
CLINICAL_TRIALS study record update · 2025-12-18Bone Marrow Grafting for Leukemia and Lymphoma
-
CLINICAL_TRIALS study record update · 2025-12-17A Multicenter, Open-label, Interventional Phase I Trial to Determine the Dose and Evaluate the Pharmacokinetics (PK) and Safety of Lutetium Lu 177 Edotreotide Targeted Radiopharmaceutical Therapy (RPT) as Monotherapy or Following Standard of Care (SoC) for the Treatment of Somatostatin Receptor-positive Tumors in the Pediatric Population (KinLET).
-
CLINICAL_TRIALS study record update · 2025-12-16Shanghai Lymphoma Clinical Cohort
-
CLINICAL_TRIALS study record update · 2025-12-16Precision Physical Exercise for Personalized Onco-Hematology.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-15Application of Telemedicine to the Management of Aggressive Lymphomas: a Regional Comparative Study
-
CLINICAL_TRIALS study record update · 2025-12-15Pediatric and Young Adult Leukemia Adoptive Therapy (PLAT)-05: A Phase 1 Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia
-
CLINICAL_TRIALS study record update · 2025-12-15A Pilot Study Evaluating Mosunetuzumab for Clearance of Detectable Minimal Residual Disease in Chronic Lymphocytic Leukemia
-
CLINICAL_TRIALS study record update · 2025-12-08A Phase I Study of Autologous Activated T-cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch in Subjects With Relapsed/Refractory B-cell Lymphoma
-
CLINICAL_TRIALS study record update · 2025-12-05A Phase I/II Study of Neratinib in Pediatric Patients With Relapsed or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-12-04A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients
-
CLINICAL_TRIALS study record update · 2025-12-02PET-CT Imaging Findings and Metabolic Parameters in Elderly Patients With Lymphoma
-
CLINICAL_TRIALS study record update · 2025-11-26Liquid Biopsy Evaluation and Repository Development at Princess Margaret
-
CLINICAL_TRIALS study record update · 2025-11-24DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial): An Umbrella-Basket Platform Trial to Evaluate the Efficacy of Targeted Therapies in Rare Adult, Paediatric and Teenage/Young Adult (TYA) Cancers With Actionable Genomic Alterations, Including Common Cancers With Rare Actionable Alterations. Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers
-
CLINICAL_TRIALS study record update · 2025-11-19A Phase 1/2, Open-Label, Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity Study of Repotrectinib in Pediatric and Young Adult Subjects With Advanced or Metastatic Malignancies Harboring ALK, ROS1, NTRK1-3 Alterations
-
CLINICAL_TRIALS study record update · 2025-11-18Molecular Characterization of Solid Tumors and Lymphomas to Optimize the Drug Development Process and Patients Enrollment in Early Phase Clinical Trials
-
CLINICAL_TRIALS study record update · 2025-11-18Prospective Observational Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
-
CLINICAL_TRIALS study record update · 2025-11-10Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2025-11-10Cognitive Behavioral Therapy (CBT) Intervention for Cancer Related Fatigue (CRF) in Patients With AML and Lymphoma
-
CLINICAL_TRIALS study record update · 2025-11-04Phase I Study of N-Acetylcysteine to Optimize Metabolic Tumor Microenvironment in CD19 CAR T-cell Therapy in Lymphoma
-
CLINICAL_TRIALS study record update · 2025-10-31Administration of TGF-b Resistant LMP-Specific Cytotoxic T-Lymphocytes to Patients With Relapsed EBV-Positive Lymphoma
-
CLINICAL_TRIALS study record update · 2025-10-31Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
-
CLINICAL_TRIALS study record update · 2025-10-31UNRELATED AND PARTIALLY MATCHED RELATED DONOR PERIPHERAL STEM CELL TRANSPLANTATION WITH Alpha/Beta T CELL AND B CELL DEPLETION FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES
-
CLINICAL_TRIALS study record update · 2025-10-30Living Well With Lymphoma: Improving Diet Quality to Improve Energy, Sleep and Quality of Life
-
CLINICAL_TRIALS study record update · 2025-10-27REBOUND: REsiliency in Older Adults UNDergoing BOne Marrow Transplant - A Pilot Study of Resiliency Measures in Older Patients Undergoing Allogeneic Blood and Marrow Transplant